September 2018 Vol 9, No 9
On behalf of the Editorial Board of the Journal of Oncology Navigation & Survivorship (JONS), it's my pleasure to offer the current issue. Each month, we aim to present navigators with an array of topics relevant to their practice. To achieve our goal, we publish original navigation research, treatment updates, interviews, and navigation best practices. Some highlights from the current issue follow.
A New Day for Patients with Melanoma: Raising Awareness About Prevention and the Latest Treatment Options
An interview with Stephanie Whitten of Meredith’s Mission for Melanoma and Matthew Fox, MD, of The University of Texas
Clinical trials have improved the treatment of cancer, and it has been shown that participants in cancer clinical trials have better outcomes than does the population at large.
Margaret L. Longacre, PhD, Melissa F. Miller, PhD, MPH, Mitch Golant, PhD, Alexandra Zaleta, PhD, Joanne S. Buzaglo, PhD
Family caregivers are integral to patient care in oncology, including attending appointments in which care options are discussed or decisions are made. The involvement of caregivers in oncology care will only increase as practice recommendations and policies are encouraging their inclusion. Yet, we do not fully understand the treatment decision-making (TDM) dynamics between patients and their caregivers or the capacity among caregivers to make care decisions. Further, caregivers' communication with a patient or healthcare team (HCT) remains underexplored in understanding shared decision-making.
Do administrators really understand the needs of the navigator, and are they fully aware of the infrastructure needed for their navigation programs? In a discussion on administrative engagement in navigation programs at the AONN+ Midyear Conference, Tricia Strusowski, RN, MS, posed these and other provocative questions to attendees.
New prostate cancer guidelines issued by the National Comprehensive Cancer Network (NCCN) continue to support early detection efforts in well-informed, healthy men while acknowledging that optimal screening of high-risk patients is not completely known. The guidelines also support the use of active surveillance in men who have low-risk prostate cancer.
First NCCN Guidelines for Management of Persons Living with HIV: Don’t Use HIV Status Alone When Making Treatment Decisions
HIV status alone should not be used for cancer treatment decision-making, according to the first guidelines from the National Comprehensive Cancer Network (NCCN) on the management of cancer in persons infected with HIV
The delivery and receipt of cancer care in value-based healthcare models was the subject of a roundtable discussion at the National Comprehensive Cancer Network (NCCN) 23rd Annual Conference.
Results 1 - 8 of 8